118 related articles for article (PubMed ID: 22192783)
1. Epigenetic modulation of the HeLa cell membrane N-glycome.
Horvat T; Mužinić A; Barišić D; Bosnar MH; Zoldoš V
Biochim Biophys Acta; 2012 Sep; 1820(9):1412-9. PubMed ID: 22192783
[TBL] [Abstract][Full Text] [Related]
2. Reversibility of membrane N-glycome of HeLa cells upon treatment with epigenetic inhibitors.
Horvat T; Deželjin M; Redžić I; Barišić D; Herak Bosnar M; Lauc G; Zoldoš V
PLoS One; 2013; 8(1):e54672. PubMed ID: 23336012
[TBL] [Abstract][Full Text] [Related]
3. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation.
Dannenberg LO; Chen HJ; Tian H; Edenberg HJ
Alcohol Clin Exp Res; 2006 Jun; 30(6):928-37. PubMed ID: 16737450
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S
Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
Mori T; Kim J; Yamano T; Takeuchi H; Huang S; Umetani N; Koyanagi K; Hoon DS
Cancer Res; 2005 Mar; 65(5):1800-7. PubMed ID: 15753377
[TBL] [Abstract][Full Text] [Related]
8. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2'-deoxycytidine.
Enright BP; Kubota C; Yang X; Tian XC
Biol Reprod; 2003 Sep; 69(3):896-901. PubMed ID: 12748129
[TBL] [Abstract][Full Text] [Related]
10. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Modification Agents Improve Gene-Specific Methylation Reprogramming in Porcine Cloned Embryos.
Huan Y; Wu Z; Zhang J; Zhu J; Liu Z; Song X
PLoS One; 2015; 10(6):e0129803. PubMed ID: 26068219
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of death of crayfish glial cells but not neurons induced by photodynamic impact.
Sharifulina SA; Komandirov MA; Uzdensky AB
Brain Res Bull; 2014 Mar; 102():15-21. PubMed ID: 24502940
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.
To SQ; Takagi K; Miki Y; Suzuki K; Abe E; Yang Y; Sasano H; Simpson ER; Knower KC; Clyne CD
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):331-8. PubMed ID: 22929011
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the glycome after HDAC inhibition impact oncogenic potential in epigenetically plastic SW13 cells.
Montgomery MR; Hull EE
BMC Cancer; 2019 Jan; 19(1):79. PubMed ID: 30651077
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
17. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression.
Gao A; Zuo X; Liu Q; Lu X; Guo W; Tian L
Toxicol Lett; 2010 Jun; 195(2-3):114-8. PubMed ID: 20230882
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines.
Kato N; Fujimoto H; Yoda A; Oishi I; Matsumura N; Kondo T; Tsukada J; Tanaka Y; Imamura M; Minami Y
Cell Death Differ; 2004 Dec; 11 Suppl 2():S153-61. PubMed ID: 15153943
[TBL] [Abstract][Full Text] [Related]
20. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
